1
EXHIBIT 10.37
OPTION AMENDMENT AGREEMENT
This Option Amendment Agreement (this "AGREEMENT") is made effective as
of November 3, 1997 by and between La Jolla Pharmaceutical Company, a Delaware
corporation (the "COMPANY") and ▇▇▇▇▇ ▇. ▇▇▇▇▇▇ ("EXECUTIVE").
Executive has received grants of options to purchase common stock of the
Company pursuant to the Company's 1994 Stock Incentive Plan (the "PLAN") (such
options granted to Executive prior to December 31, 1997 being referred to herein
as the "OPTIONS"), and the Company and Executive desire to amend the terms of
the Options as set forth herein in consideration of Executive's ongoing
employment.
Therefore, notwithstanding anything in the Plan or the terms of grant of
the Options to the contrary, the Company and Executive hereby agree that if a
Change in Control of the Company (as defined in the Plan in its form as of the
date hereof) occurs and Executive's employment with the Company or its successor
is terminated by the Company or its successor, or if such a Change in Control
occurs and Executive's employment with the Company or its successor is
terminated by Executive following any change in Executive's title to any
position other than Vice-President or any material reduction by the Company or
its successor in Executive's responsibilities (other than any such reduction
that is commensurate with Executive's assumption of the position of
Vice-President of the surviving company), or any requirement that Executive's
place of employment be in other than the San Diego area, then all Options shall
automatically vest and become fully exercisable as of the date of termination of
Executive's employment (the "TERMINATION DATE"), notwithstanding any vesting or
performance conditions applicable thereto, and shall remain exercisable for a
period of one year following the Termination Date or such longer period as is
provided by the Plan or grant pursuant to which such Options were received,
provided that in no case will such Options be exercisable beyond the duration of
the original term thereof, and provided further that nothing herein is intended
to require the extension of the exercise period of any Option that qualifies as
an incentive stock option under the Internal Revenue Code and applicable
regulations thereunder, and the exercise period thereof shall not be extended
beyond the termination date otherwise provided by the award grant unless
Executive, in his sole and unqualified discretion, elects to forego incentive
stock option treatment and extend the exercise period thereof as provided
herein. This Agreement does not apply to any options granted to Executive after
December 31, 1997.
IN WITNESS WHEREOF, Executive and the Company have entered into this
Amendment as of the date written above.
LA JOLLA PHARMACEUTICAL COMPANY
By: /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
-------------------------- --------------------
Name: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
--------------------------
Title: Chairman & CEO
-------------------------
